Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA
634 results:

  • 1. Association of the Advanced Lung cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer.
    Jiang H; Li B; Wu M; Wang Q; Li Y
    BMC Cancer; 2024 Apr; 24(1):428. PubMed ID: 38589844
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The feasibility and acceptability of an app-based intervention with brief behavioural support (APPROACH) to promote brisk walking in people diagnosed with breast, prostate and colorectal cancer in the UK.
    Lally P; Kennedy F; Smith S; Beeken RJ; Buck C; Thomas C; Counsell N; Wyld L; Martin C; Williams S; Roberts A; Greenfield DM; Gath J; Potts HWW; Latimer N; Smith L; Fisher A
    Cancer Med; 2024 Mar; 13(6):e7124. PubMed ID: 38529687
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Canonical DDR activation by EMT inducing agent 5-Fluorouracil is modulated by a cannabinoid based combinatorial approach via inducing autophagy and suppression of vimentin expression.
    Mir KB; Chakraborty S; Amin T; Kumar A; Rouf War A; Nalli Y; Kumar R; Dinesh Kumar L; Ali A; Goswami A
    Biochem Pharmacol; 2024 May; 223():116126. PubMed ID: 38490521
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Examining cancer screening disparities by race/ethnicity and insurance groups: A comparison of 2008 and 2018 National Health Interview Survey (NHIS) data in the United States.
    Sun J; Frick KD; Liang H; Chow CM; Aronowitz S; Shi L
    PLoS One; 2024; 19(2):e0290105. PubMed ID: 38416784
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Integrated bioinformatics approach to unwind key genes and pathways involved in colorectal cancer.
    Mobeen SA; Saxena P; Jain AK; Deval R; Riazunnisa K; Pradhan D
    J Cancer Res Ther; 2023 Oct; 19(7):1766-1774. PubMed ID: 38376276
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Tumor acidosis-induced DNA damage response and tetraploidy enhance sensitivity to atm and ATR inhibitors.
    Aubert L; Bastien E; Renoult O; Guilbaud C; Özkan K; Brusa D; Bouzin C; Richiardone E; Richard C; Boidot R; Léonard D; Corbet C; Feron O
    EMBO Rep; 2024 Mar; 25(3):1469-1489. PubMed ID: 38366255
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in colorectal cancer.
    Singh H; Sahgal P; Kapner K; Corsello SM; Gupta H; Gujrathi R; Li YY; Cherniack AD; El Alam R; Kerfoot J; Andrews E; Lee A; Nambiar C; Hannigan AM; Remland J; Brais L; Leahy ME; Rubinson DA; Schlechter BL; Meyerson M; Kuang Y; Paweletz CP; Lee JK; Quintanilha JCF; Aguirre AJ; Perez KJ; Huffman BM; Rossi H; Abrams TA; Kabraji S; Trusolino L; Bertotti A; Sicinska ET; Parikh AR; Wolpin BM; Schrock AB; Giannakis M; Ng K; Meyerhardt JA; Hornick JL; Sethi NS; Cleary JM
    Clin Cancer Res; 2024 Apr; 30(8):1669-1684. PubMed ID: 38345769
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Discovery of the first ataxia telangiectasia and Rad3-related (ATR) degraders for cancer treatment.
    Huang L; Shao J; Lai W; Gu H; Yang J; Shi S; Wufoyrwoth S; Song Z; Zou Y; Xu Y; Zhu Q
    Eur J Med Chem; 2024 Mar; 267():116159. PubMed ID: 38325007
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Alterations in the gut microbiota and their metabolites in human intestinal epithelial cells of patients with colorectal cancer.
    Jahani-Sherafat S; Azimirad M; Raeisi H; Azizmohammad Looha M; Tavakkoli S; Ahmadi Amoli H; Moghim S; Rostami-Nejad M; Yadegar A; Zali MR
    Mol Biol Rep; 2024 Feb; 51(1):265. PubMed ID: 38302841
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/atm Inhibitors in colorectal cancer.
    Zhang M; Li X; Herman JG; Gao A; Wang Q; Yao Y; Shen F; He K; Guo M
    Clin Transl Gastroenterol; 2024 Mar; 15(3):e00682. PubMed ID: 38235705
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells.
    Sogari A; Rovera E; Grasso G; Mariella E; Reilly NM; Lamba S; Mauri G; Durinikova E; Vitiello PP; Lorenzato A; Avolio M; Piumatti E; Bonoldi E; Aquilano MC; Arena S; Sartore-Bianchi A; Siena S; Trusolino L; Donalisio M; Russo M; Di Nicolantonio F; Lembo D; Bardelli A
    Cell Rep Med; 2024 Feb; 5(2):101376. PubMed ID: 38228147
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. DNA polymerase ε and δ variants drive mutagenesis in polypurine tracts in human tumors.
    Ostroverkhova D; Tyryshkin K; Beach AK; Moore EA; Masoudi-Sobhanzadeh Y; Barbari SR; Rogozin IB; Shaitan KV; Panchenko AR; Shcherbakova PV
    Cell Rep; 2024 Jan; 43(1):113655. PubMed ID: 38219146
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. colorectal cancer Screening in the Elderly: Does Increased Prevalence Necessitate Tighter Surveillance.
    Suki M; Abu-Baker F; Beshara A; Ovadia B; Gal O; Kopelman Y
    Isr Med Assoc J; 2023 Dec; 25(12):815-818. PubMed ID: 38142321
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Colonic stent as a bridge to surgery versus emergency rection for malignant left-sided colorectal obstruction: A systematic review and meta-analysis of randomized controlled trials.
    Shang R; Han X; Zeng C; Lv F; Fang R; Tian X; Ding X
    Medicine (Baltimore); 2023 Dec; 102(50):e36078. PubMed ID: 38115371
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Risks of hypertension and thromboembolism in patients receiving bevacizumab with chemotherapy for colorectal cancer: A systematic review and meta-analysis.
    Chitkara A; Kaur N; Desai A; Mehta D; Anamika F; Sarkar S; Gowda N; Sethi P; Thawani R; Chen EY
    Cancer Med; 2023 Dec; 12(24):21579-21591. PubMed ID: 38069531
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [The structure of pathogenic germline variants in colorectal cancer in Moscow patients].
    Semenova AB; Byakhova MM; Makarova MV; Galkin VN; Nemtsova MV; Chernevskiy DK; Danishevich AM; Shatalov VG; Babkina AV; Popova NG; Gadzhieva SM
    Arkh Patol; 2023; 85(6):16-25. PubMed ID: 38010635
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Rate of Pathogenic Germline Variants in Patients With Lung cancer.
    Sorscher S; LoPiccolo J; Heald B; Chen E; Bristow SL; Michalski ST; Nielsen SM; Lacoste A; Keyder E; Lee H; Nussbaum RL; Martins R; Esplin ED
    JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells.
    Chen M; Mashima T; Oishi T; Muramatsu Y; Seto Y; Takamatsu M; Kawata N; Morino S; Nakamura A; Inaba S; Yuan X; Maruyama K; Suzuki M; Sato A; Yoshida H; Jang MK; Mizutani A; Takeuchi K; Yamaguchi K; Shirai F; Nagayama S; Katayama R; Seimiya H
    Br J Cancer; 2024 Jan; 130(1):151-162. PubMed ID: 37968472
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Determining Stable Structure and in Vitro Antiproliferative Properties of a Novel 3-(2-((4-Trifluoromethyl)phenyl)amino)thiazol-4-yl)-2H-chromen-2-one Molecule.
    Burak Sarigüney A; Karakaş Sarikaya E; Pehlivanoğlu S
    Chem Biodivers; 2024 Jan; 21(1):e202301216. PubMed ID: 37870095
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and atm, a Belgian Precision tumor-agnostic phase II study.
    Joris S; Denys H; Collignon J; Rasschaert M; T'Kint de Roodenbeke D; Duhoux FP; Canon JL; Tejpar S; Mebis J; Decoster L; Aftimos P; De Grève J
    ESMO Open; 2023 Dec; 8(6):102041. PubMed ID: 37852034
    [TBL] [Abstract] [Full Text] [Related]  


    of 32.